Initiatives to create comparative effectiveness studies within the Medicare program -- supporting increased transparency/reporting requirements. Patent Reform -- S. 1145 and HR 1908 provisions related to apportionment of damages, inequitable conduct, and post-grant/second window. Follow on Biologics, including HR 1956, HR 1038, and HR 5629.  Generating support for Committee/House consideration.
MMM - Medicare/Medicaid CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
KATHLEEN TREGONING (Staff, Senate Budget Committee) ADAM GLUCK (Staff, Senate Appropriations Committee) KATHLEEN TREGONING (Staff, Senate Budget Committee) ADAM GLUCK (Staff, Senate Appropriations Committee) KATHLEEN TREGONING (Staff, Senate Budget Committee) ADAM GLUCK (Staff, Senate Appropriations Committee)
Staff, Senate Budget Committee Staff, Senate Appropriations Committee Staff, Senate Budget Committee Staff, Senate Appropriations Committee Staff, Senate Budget Committee Staff, Senate Appropriations Committee